NASDAQ: RGEN - Repligen Corporation

Yield per half year: +19.19%
Sector: Healthcare

Repligen Corporation

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
227.97 48.72 367.9% 176.55 +29.13%
P/S 12.83 33.75 -61.98%
P/BV 4.13 4.82 -14.27%
P/FCF 117.44 61 92.53%
Ev/Ebitda 63.2 -22.17 -385.07%
Ev/S 12.77 22.56 -43.39%
Ev/FCF 107.77 68.75 56.76%
E/P 0.004 0.0178 -77.49%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
20.2 4.98 305.96% 25.57 -21%
ROE 1.81 9.61 -81.21%
ROA 1.26 0.3443 265.65%
ROIC 7.71 7.63 0.9909%
ROS 5.63 -25.17 -122.37%
ROCE 2.22 15.35 -85.53%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
5.57 -3.68 -251.57% 4.07 +36.75%
Nеt Debt/Ebitda -0.3093 -3.44 -91%
Debt/Ratio 0.2514 0.1985 26.67%
Debt/Equity 3.73 1.66 124.55%
Debt/Net Income 20 10.32 93.7%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5473 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.498 -100%
Average percentage for payments 275.82 43.56 533.13%
Difference from average difference in sector -0.5473

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
8/10
72.78 -56.89 -227.93%
Growth impulse Ebitda in 5 years 30.37 -54.68 -155.54%
Growth impulse Net Income in 5 years -40.67 -58.33 -30.28%
Growth impulse FCF in 5 years 108.14 -49.48 -318.55%
Growth impulse EPS in 5 years -43.12 -32.41 33.05%
IP Score
3.09/10

Similar companies

Illumina

Amarin

ImmunoGen

DENTSPLY SIRONA

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription